HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rong Zhang Selected Research

repaglinide (Prandin)

3/2016Joint effects of diabetic-related genomic loci on the therapeutic efficacy of oral anti-diabetic drugs in Chinese type 2 diabetes patients.
5/2015A variant of PSMD6 is associated with the therapeutic efficacy of oral antidiabetic drugs in Chinese type 2 diabetes patients.
2/2012Association of a SLC30A8 genetic variant with monotherapy of repaglinide and rosiglitazone effect in newly diagnosed type 2 diabetes patients in China.
4/2010A variation in NOS1AP gene is associated with repaglinide efficacy on insulin resistance in type 2 diabetes of Chinese.
8/2008Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rong Zhang Research Topics

Disease

192Neoplasms (Cancer)
08/2022 - 01/2002
76Infections
12/2022 - 01/2008
62Type 2 Diabetes Mellitus (MODY)
05/2022 - 01/2003
49Inflammation (Inflammations)
07/2022 - 01/2008
24Neoplasm Metastasis (Metastasis)
11/2022 - 10/2007
23Cognitive Dysfunction
08/2022 - 02/2013
23Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2021 - 06/2004
22Body Weight (Weight, Body)
01/2021 - 01/2002
21Hepatocellular Carcinoma (Hepatoma)
11/2022 - 09/2010
21Carcinogenesis
07/2022 - 03/2007
21Hypoxia (Hypoxemia)
07/2022 - 12/2003
21Insulin Resistance
03/2022 - 02/2007
19Carcinoma (Carcinomatosis)
08/2022 - 01/2010
19Obesity
01/2022 - 01/2007
17Hypertension (High Blood Pressure)
01/2022 - 04/2005
16Lung Neoplasms (Lung Cancer)
07/2022 - 10/2007
16Alzheimer Disease (Alzheimer's Disease)
07/2022 - 07/2011
16Cardiovascular Diseases (Cardiovascular Disease)
05/2022 - 04/2005
16Fibrosis (Cirrhosis)
01/2022 - 06/2009
16COVID-19
01/2022 - 01/2020
15Ischemia
10/2022 - 05/2002
15Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 03/2002
14Adenocarcinoma
08/2022 - 01/2002
14Lung Injury
01/2022 - 08/2013
14Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 10/2007
13Sepsis (Septicemia)
01/2022 - 03/2008
12Breast Neoplasms (Breast Cancer)
03/2022 - 05/2008
12Wounds and Injuries (Trauma)
03/2022 - 10/2002
11Autism Spectrum Disorder
12/2022 - 10/2016
11Reperfusion Injury
10/2022 - 05/2002
11Pneumonia (Pneumonitis)
01/2022 - 01/2008
11Stroke (Strokes)
01/2022 - 01/2004
11Glioma (Gliomas)
01/2021 - 03/2007
10Pain (Aches)
11/2022 - 07/2012
10Non-alcoholic Fatty Liver Disease
10/2021 - 05/2013
10Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 04/2009
9Glaucoma
10/2022 - 08/2012
9Autistic Disorder (Autism)
02/2022 - 06/2012
9Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 03/2003
9Cardiomegaly (Heart Hypertrophy)
08/2021 - 01/2002
9Melanoma (Melanoma, Malignant)
05/2021 - 01/2013
9Lymphatic Metastasis
09/2020 - 04/2003
9Leukemia
01/2018 - 12/2011
8Pulmonary Fibrosis (Fibrosing Alveolitis)
10/2022 - 06/2009
8Stomach Neoplasms (Stomach Cancer)
08/2022 - 12/2016
8Atherosclerosis
01/2022 - 05/2014
8Liver Neoplasms (Liver Cancer)
01/2021 - 08/2004
8Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 08/2011
8Myocardial Infarction
11/2017 - 04/2005
7Hypertrophy
05/2022 - 04/2005

Drug/Important Bio-Agent (IBA)

100Proteins (Proteins, Gene)FDA Link
10/2022 - 09/2006
43Biomarkers (Surrogate Marker)IBA
07/2022 - 09/2009
38Glucose (Dextrose)FDA LinkGeneric
03/2022 - 05/2002
36Pharmaceutical PreparationsIBA
06/2022 - 01/2004
31MicroRNAs (MicroRNA)IBA
06/2022 - 01/2010
27Anti-Bacterial Agents (Antibiotics)IBA
12/2022 - 10/2002
22Biological ProductsIBA
01/2022 - 01/2010
21DNA (Deoxyribonucleic Acid)IBA
06/2022 - 05/2003
20Carbapenems (Carbapenem Antibiotics)IBA
12/2022 - 12/2014
19Peptides (Polypeptides)IBA
06/2022 - 07/2011
19CytokinesIBA
01/2022 - 05/2010
19Therapeutic UsesIBA
01/2022 - 08/2008
18EnzymesIBA
06/2022 - 09/2008
18AntigensIBA
01/2022 - 05/2005
17Messenger RNA (mRNA)IBA
01/2022 - 03/2008
16Particulate MatterIBA
06/2022 - 11/2019
16Amyloid (Amyloid Fibrils)IBA
01/2022 - 07/2011
15LipidsIBA
01/2022 - 01/2003
13Oxygen (Dioxygen)IBA
05/2022 - 02/2006
12Neuroprotective AgentsIBA
10/2022 - 04/2012
12RNA (Ribonucleic Acid)IBA
08/2022 - 01/2015
12Colistin (Coly-Mycin)FDA Link
06/2022 - 01/2016
12Insulin (Novolin)FDA Link
05/2022 - 08/2008
12Cisplatin (Platino)FDA LinkGeneric
01/2021 - 04/2003
11Interleukin-6 (Interleukin 6)IBA
10/2021 - 01/2007
10CateninsIBA
08/2021 - 09/2015
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 12/2003
10CholesterolIBA
03/2020 - 04/2004
9Tigecycline (Tygacil)FDA Link
06/2022 - 07/2018
9Blood Glucose (Blood Sugar)IBA
06/2022 - 07/2007
9Small Interfering RNA (siRNA)IBA
04/2022 - 02/2010
9Uric Acid (Urate)IBA
01/2022 - 01/2015
9VaccinesIBA
01/2022 - 01/2015
9Long Noncoding RNAIBA
12/2020 - 01/2016
8AcidsIBA
01/2022 - 02/2006
8C-Reactive ProteinIBA
01/2022 - 03/2015
8Antiviral Agents (Antivirals)IBA
10/2021 - 01/2017
8Indicators and Reagents (Reagents)IBA
02/2021 - 01/2014
7Oxytocin (Pitocin)FDA LinkGeneric
10/2022 - 07/2012
7SootIBA
07/2022 - 12/2014
7AntibodiesIBA
01/2022 - 05/2011

Therapy/Procedure

94Therapeutics
05/2022 - 01/2004
42Drug Therapy (Chemotherapy)
01/2022 - 01/2002
18Radiotherapy
01/2022 - 01/2002
16Immunotherapy
01/2022 - 02/2015
15Neoadjuvant Therapy
11/2022 - 04/2003
11Aftercare (After-Treatment)
01/2022 - 04/2010
11Acupuncture Points (Acupuncture Point)
01/2022 - 06/2012
8High-Intensity Focused Ultrasound Ablation
05/2022 - 04/2015
8Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2020 - 04/2005